Open-source COVID-19 vaccine PVX-001 enters Phase 1 human trial
An open-source COVID-19 vaccine candidate designated PVX-001 has initiated a Phase 1 clinical trial. The vaccine is being developed by PopVax, as reported on the Hacker News platform. This initial trial phase will assess the vaccine's safety and immune response in human subjects. The project aims to provide a transparent, publicly accessible vaccine development model. The news garnered community attention but had not yet generated extensive public discussion at the time of reporting.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in